A Phase III Clinical Trial of Duloxetine in Participants With Fibromyalgia.
Phase of Trial: Phase III
Latest Information Update: 01 Feb 2018
At a glance
- Drugs Duloxetine (Primary)
- Indications Fibromyalgia
- Focus Registrational; Therapeutic Use
- Sponsors Eli Lilly
- 16 Jan 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 06 Jun 2013 Planned End Date changed from 1 Feb 2014 to 1 Dec 2013 as reported by ClinicalTrials.gov.